Visual and anatomical outcomes of spironolactone therapy in patients with chronic central serous chorioretinopathy
Purpose: To evaluate the effect of spironolactone on chronic central serous chorioretinopathy (CSC). Methods: In this prospective interventional case series, patients with chronic cSc were treated with spironolactone (25 mg daily) for at least 6 weeks. If the subretinal fluid (SRF) had not completel...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2017-01-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | http://www.jovr.org/article.asp?issn=2008-322X;year=2017;volume=12;issue=3;spage=281;epage=289;aulast=Falavarjani |